Sentinel Lymph Node Biopsy for Uterine Cancer

Sentinel Lymph Node Biopsy for Uterine Cancer - Senti-OMC

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028524

Enrollment

400

Registered

2017-08-03

Start date

2017-08-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterin cancer

Interventions

During surgery

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: cervical cancer of stage IA, IB and IIA1 with diameter of 2cm endometrial cancer of stage Ia1 and grade 1 or 2

Exclusion criteria

Exclusion criteria: advanced cancer

Design outcomes

Primary

Measure	Time frame
lyph node recurrence rate, progression free survival, overall survival	—

Countries

Japan

Contacts

Public ContactTomohito Tanaka

Osaka Medical College Department of Obstetrics and Gynecology

gyn123@osaka-med.ac.jp072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026